This finding is significant, because it not only could offer us a new view on RASSF1A as a tumour suppressor gene by regulating miRNA expression, but it might also provide us with a novel therapeutic target for gastric cancer by increasing RASSF1A expression via miR-711 regulation. This evidence concerns the gene RASSF1 and gastric cancer.